Paper Details

  1. Home
  2. Paper Details

Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).

Author: RowellN P, WilliamsC J

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Surgery is generally the preferred treatment for early-stage non-small cell lung cancer (NSCLC). However, some patients, even though they could have surgery, are unable to because of poor lung function, heart problems, or overall weakness. These patients are considered "medically inoperable". Some doctors recommend aggressive radiation therapy for these patients, while others believe it is not effective and prefer to monitor the disease and only treat symptoms when they appear. While there is limited evidence from studies to support aggressive radiation therapy for early-stage NSCLC, most cancer specialists believe that patients should receive aggressive treatment instead of just managing symptoms.
Paper Details　
Original Abstract of the Article :
In general, surgery is believed to offer the best prospects for cure for early stage non-small cell lung cancer (NSCLC). In spite of the intention to consider all patients with stage I-II disease for surgery, there are those who, although technically operable, either refuse surgery or are considered...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD002935

データ提供：米国国立医学図書館（NLM）

Radiation Therapy for Stage I/II Non-Small Cell Lung Cancer

This study examines the use of radical radiotherapy as an alternative treatment option for patients with stage I/II non-small cell lung cancer (NSCLC) who are medically inoperable. The authors discuss the challenges of managing this patient population and the role of radiotherapy in improving patient outcomes.

Radiotherapy: A Viable Option for Medically Inoperable Patients

The study acknowledges that surgery is generally considered the gold standard for early-stage NSCLC. However, for patients who are medically inoperable, radical radiotherapy offers a valuable alternative. The researchers highlight the need for further research to establish the efficacy of radical radiotherapy in this patient group.

The Role of Radiation Therapy in Cancer Management

This research contributes to the ongoing discussion surrounding the role of radiotherapy in cancer management. It emphasizes the importance of considering individual patient factors, such as medical fitness and treatment preferences, when making treatment decisions. It’s like finding the best path through a sandstorm – sometimes the best option is not the most direct, but the safest.

Dr.Camel's Conclusion

This study explores the use of radical radiotherapy for medically inoperable patients with stage I/II NSCLC. While further research is needed to confirm the effectiveness of this approach, it provides valuable insights into the complex considerations involved in managing this patient population.

Date :
  1. Date Completed 2002-02-28
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

11406051

DOI: Digital Object Identifier

10.1002/14651858.CD002935

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.